文献速递脑血管病外科神经重症

80岁以上破裂动脉瘤患者预后改善:第二后试验十年血管内治疗作为首选

Improved Outcomes Among Octogenarians with Ruptured Aneurysms: Endovascular Treatment as Right-of-First-Refusal in the Second Post-trial Decade.
PubMed 文献 · World Neurosurg · 2024-08-10

单中心回顾性分析619例aSAH中38例80岁以上患者,90%以血管内治疗为首选,中位随访17个月总死亡率39%、53%获良好神经功能结局;Hunt-Hess分级差与基线非独立功能状态与更高死亡率相关。

要点

  • 80岁以上aSAH患者占队列6%(38/619),21%为Hunt-Hess 4-5级,90%首选血管内治疗。
  • 中位随访17个月总死亡率39%,末次随访53%达到良好神经功能结局(mRS<3)。
  • Hunt-Hess 5级死亡率100%、III-IV级47%、1-2级13%(P=0.004);基线非独立者死亡率100% vs 独立者28%(P=0.002)。

核心结论

  • 在第二个后ISAT/BRAT十年,80岁以上aSAH患者的神经功能结局正在改善,尤其鉴于血管内治疗占主导。
  • 除Hunt-Hess分级外,预后判断还应考虑80岁以上患者的基线功能状态与合并症。

研究设计与样本

  • 单中心aSAH数据库回顾性分析,纳入年龄80岁及以上接受动脉瘤治疗的患者。
  • 共38例80岁以上患者,占该aSAH队列619例的6%。

主要发现

  • 21%为Hunt-Hess 4-5级,90%患者以血管内治疗为首选方式。
  • 中位随访17个月,总死亡率为39%。
  • 死亡率随Hunt-Hess分级升高:5级100%、III-IV级47%、1-2级13%(P=0.004)。
  • 基线非独立功能状态者死亡率100%,独立者28%(P=0.002)。
  • 末次随访53%患者获得良好神经功能结局;Hunt-Hess I-II级为80%,病前独立功能状态或衰弱组分少于5项者超过60%(与较差对应组比较P≤0.02)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment outcomes of octogenarians with aneurysmal subarachnoid hemorrhage (aSAH) are often considered poor. With ongoing advancements and experience in endovascular technology, we sought to evaluate the outcomes of octogenarians treated for aSAH in the second post-International Subarachnoid Aneurysm Trial (ISAT)/Barrow Ruptured Aneurysm Trial (BRAT) decade. METHOD: A single-center database of aSAH was reviewed to identify patients aged 80 years or above undergoing aneurysm treatment. Mortality and favorable neurologic outcome (defined as modified Rankin Scale score <3) were assessed among the series and compared across several subgroups. RESULTS: Octogenarian patients constituted 6% of the aSAH cohort (38 of 619) over the reviewed period. Twenty-one percent were high grade (Hunt-Hess grade 4-5). Endovascular treatment was the first-line modality in 90% of patients. During a median follow-up of 17 months, the overall mortality was 39%. Higher mortality was associated with poor Hunt-Hess grade (100% for grade 5, 47% for III-IV, 13% for 1-2, P = 0.004) and non-independent baseline function status (100% mortality for non-independent vs. 28% for independent group, P = 0.002). At last follow-up, 53% of patients achieved a favorable neurologic outcome. The stratified rate was 80% in Hunt-Hess grade I-II and over 60% in patients with premorbid independent function status or less than 5 frailty components (P ≤ 0.02 vs. poorer counterparts). CONCLUSIONS: Neurologic outcomes of octogenarian patients with aSAH are improving in the second post-trial decade, particularly given the preponderance of endovascular treatment. Baseline functional status and comorbidities of octogenarians should be considered in addition to the Hunt-Hess grade in prognostication.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ma L, Hoz SS, Al-Bayati AR, et al. Improved Outcomes Among Octogenarians with Ruptured Aneurysms: Endovascular Treatment as Right-of-First-Refusal in the Second Post-trial Decade. World Neurosurg. 2024. PMID: 39134300. doi:10.1016/j.wneu.2024.08.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。